When data from two data sources were analyzed -- one of commercial health insurance claims, the other from Medicare -- ...
de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .
Niyondiko, N. (2024) Clinical Management of Diabetic Ketoacidosis in Pregnancy: A Review of Current Literature. Open Access Library Journal, 11, 1-25. doi: 10.4236/oalib.1112246 .
If we can actually get to patients more quickly, we have the potential to improve upon the treatment effects we already saw in the ... whom I've had review our statistical analysis plan. Based upon ...
"We are driven to deliver leading innovations to the dental market and support our customers in creating the beautiful, healthy smiles patients want ... variability into treatment. Misplaced and ...
A new treatment that could prevent blindness in children with the CLN2 type Batten disease has been trialed by clinicians and ...
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and ...
A new approach helps examine the proportion of cancerous and healthy stem cells in patients with chronic myeloid leukemia and how this influences treatment outcomes.
All you need to do is choose the templates you love and add your contact info, and then post them to your favorite social platform. The most successful agents have a marketing plan that’s ...
“Dentists know what their patients require.” Reports say that over 89 per cent of oral health providers across the nation are providing some form of care under the plan. Up to nine million ...
CHICAGO (CBS) – A groundbreaking treatment for type 1 diabetes is showing promising results for patients in Chicago. It's a minimally invasive procedure that could mean diabetics don't have to ...
Enzalutamide is a hormone treatment. Talazoparib is a PARP inhibitor, a drug that stops damaged cancer cells from repairing themselves. “Having a novel combination of well-tolerated medications ...